Skip to main content

Michael J. Finney, Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Vaxart, Inc. publishes a filing, an earnings call transcript or a press release.

Get VXRT alerts

About Michael J. Finney, Ph.D.

Michael J. Finney, Ph.D. is recorded as Board Member at Vaxart, Inc. (VXRT) since June 11, 2024. Vaxart, Inc. reported in an 8-K filed September 2, 2025 that Michael J. Finney, Ph.D. retired as Chair of the Board, effective September 30, 2025. Vaxart, Inc. reported in an 8-K filed June 13, 2024 that Michael J. Finney, Ph.D. was appointed Director, effective June 11, 2024. Vaxart, Inc. reported in an 8-K filed March 6, 2024 that Michael J. Finney, Ph.D. resigned as Interim President and Chief Executive Officer, effective March 18, 2024. Equibles holds 4 filed executive changes naming Michael J. Finney, Ph.D.; each is listed under recent activity with its source filing. Vaxart, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vaxart, Inc. includes Andrei Floroiu (CEO), Michael Finney (CEO), Michael J. Finney (CEO and Board Member) and 7 others.

“On September 2, 2025, Michael J. Finney, Ph.D. provided notice of his retirement from the board of directors (the "Board") of Vaxart, Inc. (the "Company"), including as Chair of the Board and as Chair and a member of the Science and Technology Committee, effective September 30, 2025.”
Vaxart, Inc. Form 8-K, filed September 2, 2025 · Read the filing
“Stockholders elected the six nominees for directors to serve until the Company's 2025 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified.”
Vaxart, Inc. Form 8-K, filed June 13, 2024 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2022-08-25–present

Leadership on record at Vaxart, Inc.

Recent activity